Emerging roles of checkpoint molecules on B cells

Area of Science:

• Immunology
• Molecular Biology
• Cancer Research

Background:

• Immune checkpoint molecules critically regulate T-cell responses and are key targets for cancer immunotherapies like anti-PD-1 and anti-LAG-3.
• While primarily studied in T cells, B cells also express immune checkpoint molecules, initially considered markers for regulatory B cells.

Purpose of the Study:

• To summarize the characteristics, ligands, and functions of specific immune checkpoint molecules on B cells.
• To highlight the emerging role of B-cell checkpoints in immune regulation.

Main Methods:

• Literature review and synthesis of recent studies on B-cell immune checkpoints.
• Analysis of data on T-cell immunoglobulin and mucin domain 1 (TIM-1), T cell immunoreceptor with Ig and ITIM domains (TIGIT), and programmed cell death 1 (PD-1) expression and function in B cells.

Main Results:

• Immune checkpoint molecules such as TIM-1, TIGIT, and PD-1 are expressed on B cells.
• These molecules can intrinsically regulate B-cell activation and effector functions, extending beyond their known roles in T cells.
• The expression patterns and functions of these checkpoints on B cells are complex and context-dependent.

Conclusions:

• Immune checkpoint molecules play significant roles in modulating B-cell immunity.
• Understanding B-cell checkpoint regulation is crucial for developing novel cancer immunotherapies.
• Further research is needed to fully elucidate the therapeutic potential of targeting B-cell checkpoints.